Results revealed that ten variables—disease duration at SLE onset, respiratory involvement, menstrual abnormalities, Sjögren's syndrome, osteoporosis, Anti-RNP, CYC, MMF, biologics, and the largest daily GC dose—were significant risk factors for SLE-ONFH (Table 3). This evidence concerns the gene RNPC3 and systemic lupus erythematosus.